330 172

Full metadata record

DC FieldValueLanguage
dc.contributor.author신진호-
dc.date.accessioned2019-12-07T19:20:21Z-
dc.date.available2019-12-07T19:20:21Z-
dc.date.issued2018-04-
dc.identifier.citationJOURNAL OF HUMAN HYPERTENSION, v. 32, no. 4, page. 249-258en_US
dc.identifier.issn0950-9240-
dc.identifier.issn1476-5527-
dc.identifier.urihttps://www.nature.com/articles/s41371-017-0025-y-
dc.identifier.urihttps://repository.hanyang.ac.kr/handle/20.500.11754/118336-
dc.description.abstractHypertension is the leading cause of mortality throughout Asia. Home blood pressure monitoring has the potential to improve hypertension control and is a useful adjunct to conventional office blood pressure measurements due to its diagnostic accuracy and prognostic value in predicting cardiovascular outcomes. At present, there are no region-specific guidelines addressing the use of home blood pressure monitoring in Asia. Therefore, an expert panel was convened to address the use of home blood pressure monitoring and develop key recommendations to help guide clinical practice throughout the Asia region. The resulting recommendations support the use of home blood pressure monitoring with a validated device as an accurate adjunct for diagnosing hypertension and predicting cardiovascular outcome. Diagnosis and treatment of hypertension should still be guided by conventional office/clinic blood pressure measurements. The expert panel encourages the incorporation of home blood pressure monitoring into local clinical guidelines and offers practical recommendations to ensure continuity of care where a validated home blood pressure device is not available.en_US
dc.description.sponsorshipThe development of this article was made possible through a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HI13C0715); and a grant from the Foundation for Development of the Community (Tochigi, Japan). Editorial and writing support was provided by Howard Christian and Chris Facey of MIMS (Hong Kong) Limited and was funded by Pfizer. The meeting during which these recommendations were formulated and discussed was made possible by an unrestricted educational grant from Pfizer. However, the recommendations were developed by the HOPE Asia Network independently of Pfizer.en_US
dc.language.isoen_USen_US
dc.publisherNATURE PUBLISHING GROUPen_US
dc.subjectCORONARY-ARTERY-DISEASEen_US
dc.subjectCARDIOVASCULAR-DISEASEen_US
dc.subjectMORNING HYPERTENSIONen_US
dc.subjectMANAGEMENTen_US
dc.subjectRISKen_US
dc.subjectPOPULATIONen_US
dc.subjectGUIDELINESen_US
dc.subjectPREVALENCEen_US
dc.subjectPREDICTORen_US
dc.subjectMORTALITYen_US
dc.titleExpert panel consensus recommendations for home blood pressure monitoring in Asia: the Hope Asia Networken_US
dc.typeArticleen_US
dc.relation.no4-
dc.relation.volume32-
dc.identifier.doi10.1038/s41371-017-0025-y-
dc.relation.page249-258-
dc.relation.journalJOURNAL OF HUMAN HYPERTENSION-
dc.contributor.googleauthorPark, Sungha-
dc.contributor.googleauthorBuranakitjaroen, Peera-
dc.contributor.googleauthorChen, Chen-Huan-
dc.contributor.googleauthorChia, Yook-Chin-
dc.contributor.googleauthorDivinagracia, Romeo-
dc.contributor.googleauthorHoshide, Satoshi-
dc.contributor.googleauthorShin, Jinho-
dc.contributor.googleauthorSiddique, Saulat-
dc.contributor.googleauthorSison, Jorge-
dc.contributor.googleauthorSoenarta, Arieska Ann-
dc.relation.code2018008575-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF MEDICINE[S]-
dc.sector.departmentDEPARTMENT OF MEDICINE-
dc.identifier.pidjhs2003-


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE